Network for monitoring children's growth and obesity
Official title: CrescNet - Computer-guided, Population-based Surveillance System for Growth Disorders
Run by University of Leipzig · NCT03072537 · Data updated 2026-11-12
This study is testing a new way for doctors to track children's growth and weight to help spot any problems early and provide better care.
Quick facts
| Study type | Observational |
|---|---|
| Ages | Any age to 18 Years |
| Sex | All |
| Enrollment | 1000000 (estimated) |
| Sponsor | University of Leipzig Academic / other |
| Locations | 1 site (Leipzig, Saxony) |
| Status | Recruiting |
| Started | January 1, 1998 |
| Main results expected | January 1, 2028 |
| Study ends | January 1, 2028 |
| Registry record updated | November 7, 2023 |
| Trial ID | NCT03072537 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study include children of all ages who are seen by primary care or pediatric physicians, regardless of the reason for their visit.
✕Probably not a fit
Patients who are not seen by participating pediatricians or those with specific growth disorders that require individualized treatment may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
CrescNet is a network involving primary care physicians and pediatricians aimed at improving the early detection of growth disorders in children. It collects pseudonymized data on patients' height, weight, and head circumferences from participating pediatricians. This data is analyzed using automated algorithms and reviewed by pediatric endocrinologists to generate quarterly reports with recommendations for managing abnormal growth or weight development. The registry also facilitates epidemiological analyses to understand trends in growth data among children.
Why it matters
Potential benefit: If successful, this initiative could lead to earlier detection and intervention for growth disorders and obesity in children, improving long-term health outcomes.
How similar studies have gone: Other studies utilizing similar data collection and monitoring approaches have shown success in identifying growth disorders, indicating that this method is both tested and effective.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Population based sample with inclusion of any patient seen by primary care or institutional physician/pediatrician, regardless of the objective for the visit (well child visits, acute visits or special requests) Exclusion Criteria: none
Where it's running
-
CrescNet - University of Leipzig
Leipzig, Saxony, Germany Recruiting
Study contacts
- Principal investigator: Roland W Pfäffle, MD — University of Leipzig
- Study coordinator: Roland W Pfäffle, MD
- Email: roland.pfaeffle@medizin.uni-leipzig.de
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Peking University Weifang Birth Cohort
This project will follow pregnant women in Weifang and their children to see if pre-pregnancy and prenatal exposures affect maternal and child health up to age 18.
-
Examining how diet and nutrition affect growth and development in young children
This study looks at how the diets of young children in rural areas of Pakistan affect their growth and development compared to children from urban areas.
-
Longitudinal study of Victorian children and their parents
This study is looking at the health and wellbeing of children born in Victoria and their parents over time to see how different factors affect their physical and mental health.
-
Ocular Changes in People Using Tirzepatide or Semaglutide
This study checks whether eye structure and blood vessels change in adults with obesity who are taking semaglutide or tirzepatide as part of routine care.
-
Whole-Body Vibration Training in Women With Obesity With and Without Type 2 Diabetes
This study tests whether eight weeks of supervised whole-body vibration training changes ankle muscle activity and walking performance in women with obesity, comparing those with and without type 2 diabetes.
-
Berobenatide for knee pain in adults who are overweight or with obesity
This study tests berobenatide vs. placebo to see if it reduces knee pain and improves function while helping with weight in adults with knee osteoarthritis and overweight/obesity.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.